Compassionate use of humanized anti-HER2/neu protein, trastuzumab for metastatic breast cancer in Japan.
Authors:
- 1 October 2001
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer
- Vol. 8 (4) , 310-315
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001
- Trastuzumab in CSFJournal of Clinical Oncology, 2000
- Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic DiseaseJournal of Clinical Oncology, 1999
- Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancersOncogene, 1999